Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound and Balloon Guided Botulinum Toxin for Cricopharyngeal Achalasia
NCT06213662Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Nov 2022
- Primary completion
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of lanbotulinumtoxin-A in cricopharyngeal achalasia, sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Functional Oral Intake Scale and Rosenbek Penetration-Aspiration Scale. Started Nov 2022; status: recruiting.
02
Drugs
lanbotulinumtoxin-A
03
Conditions
cricopharyngeal achalasia
Beyond the preview
Go deeper on NCT06213662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06213662.